300246SZSE
🚨 Material Event

2026 Semi-Annual Report Summary

Baolait Technology Co., Ltd.··4 pages

✨ AI Summary

Guangdong Biolight Meditech Co., Ltd. reported a semi-annual revenue of 517.74 million RMB, representing a 1.09% decrease year-on-year. The company recorded a net loss attributable to shareholders of 34.49 million RMB, a significant decline compared to the previous year. The board has decided not to distribute cash dividends or issue bonus shares for this period. The company maintains its focus on medical technology operations despite the current financial downturn.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

I. Important Notes

This semi-annual report summary is derived from the full semi-annual report. To fully understand the company's operating results, financial position, and future development plans, investors should carefully read the full semi-annual report on the media designated by the China Securities Regulatory Commission.

All directors attended the board meeting to review this report.

Non-standard audit opinion: Not applicable.

Profit distribution plan or capital reserve conversion plan for the reporting period reviewed by the Board of Directors: Not applicable.

The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert capital reserves into share capital.

Preferred stock profit distribution plan for the reporting period approved by the Board of Directors: Not applicable.

II. Company Profile

1. Company Profile

Stock AbbreviationBiolightStock Code300246
Stock ExchangeShenzhen Stock Exchange
Contact InformationBoard SecretarySecurities Affairs Representative
NameYang YongxingLi Yunni
Telephone0756-33999090756-3399909
Office AddressBiolight Technology Park (Jinding), No. 9 Yonghe Road, High-tech Zone, Zhuhai, GuangdongBiolight Technology Park (Jinding), No. 9 Yonghe Road, High-tech Zone, Zhuhai, Guangdong
Emailir@blt.com.cnir@blt.com.cn

2. Key Accounting Data and Financial Indicators

Whether the company needs to retroactively adjust or restate previous years' accounting data: No.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.